446 related articles for article (PubMed ID: 14731193)
1. Cannabis abuse is not a risk factor for treatment outcome in methadone maintenance treatment: a 1-year prospective study in an Israeli clinic.
Weizman T; Gelkopf M; Melamed Y; Adelson M; Bleich A
Aust N Z J Psychiatry; 2004; 38(1-2):42-6. PubMed ID: 14731193
[TBL] [Abstract][Full Text] [Related]
2. Correlates of benzodiazepine abuse in methadone maintenance treatment. A 1 year prospective study in an Israeli clinic.
Bleich A; Gelkopf M; Schmidt V; Hayward R; Bodner G; Adelson M
Addiction; 1999 Oct; 94(10):1533-40. PubMed ID: 10790905
[TBL] [Abstract][Full Text] [Related]
3. Benzodiazepine abuse in a methadone maintenance treatment clinic in Israel: characteristics and a pharmacotherapeutic approach.
Bleich A; Gelkopf M; Weizman T; Adelson M
Isr J Psychiatry Relat Sci; 2002; 39(2):104-12. PubMed ID: 12227225
[TBL] [Abstract][Full Text] [Related]
4. Does psychiatric comorbidity affect drug abuse treatment outcome? A prospective assessment of drug abuse, treatment tenure and infectious diseases in an Israeli methadone maintenance clinic.
Gelkopf M; Weizman T; Melamed Y; Adelson M; Bleich A
Isr J Psychiatry Relat Sci; 2006; 43(2):126-36. PubMed ID: 16910375
[TBL] [Abstract][Full Text] [Related]
5. Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment.
Stenbacka M; Beck O; Leifman A; Romelsjö A; Helander A
Drug Alcohol Rev; 2007 Jan; 26(1):55-63. PubMed ID: 17364837
[TBL] [Abstract][Full Text] [Related]
6. Low risk for hepatitis C seroconversion in methadone maintenance treatment.
Peles E; Schreiber S; Rados V; Adelson M
J Addict Med; 2011 Sep; 5(3):214-20. PubMed ID: 21844836
[TBL] [Abstract][Full Text] [Related]
7. Depression in methadone maintenance treatment patients: rate and risk factors.
Peles E; Schreiber S; Naumovsky Y; Adelson M
J Affect Disord; 2007 Apr; 99(1-3):213-20. PubMed ID: 17055063
[TBL] [Abstract][Full Text] [Related]
8. Gender differences and pregnant women in a methadone maintenance treatment (MMT) clinic.
Peles E; Adelson M
J Addict Dis; 2006; 25(2):39-45. PubMed ID: 16785218
[TBL] [Abstract][Full Text] [Related]
9. Influence of psychiatric comorbidity on HIV risk behaviors: changes during drug abuse treatment.
King VL; Kidorf MS; Stoller KB; Brooner RK
J Addict Dis; 2000; 19(4):65-83. PubMed ID: 11110066
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of mental and physical health disorders among older methadone patients.
Rosen D; Smith ML; Reynolds CF
Am J Geriatr Psychiatry; 2008 Jun; 16(6):488-97. PubMed ID: 18515693
[TBL] [Abstract][Full Text] [Related]
11. Differences in methylphenidate abuse rates among methadone maintenance treatment patients in two clinics.
Peles E; Schreiber S; Linzy S; Domani Y; Adelson M
J Subst Abuse Treat; 2015 Jul; 54():44-9. PubMed ID: 25605438
[TBL] [Abstract][Full Text] [Related]
12. 15-Year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel.
Peles E; Schreiber S; Adelson M
Drug Alcohol Depend; 2010 Mar; 107(2-3):141-8. PubMed ID: 19914783
[TBL] [Abstract][Full Text] [Related]
13. Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in Israel.
Peles E; Schreiber S; Adelson M
Drug Alcohol Depend; 2006 May; 82(3):211-7. PubMed ID: 16219428
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of benzodiazepine abuse in methadone maintenance treatment patients: a 1 year prospective study in an Israeli clinic.
Gelkopf M; Bleich A; Hayward R; Bodner G; Adelson M
Drug Alcohol Depend; 1999 Jun; 55(1-2):63-8. PubMed ID: 10402150
[TBL] [Abstract][Full Text] [Related]
15. The first 38 methadone maintenance treatment patients in Stockholm: 15-year follow-up with a main focus on detoxification from methadone.
Hiltunen AJ; Eklund C; Borg S
Nord J Psychiatry; 2011 Apr; 65(2):106-11. PubMed ID: 20662685
[TBL] [Abstract][Full Text] [Related]
16. Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial.
Sees KL; Delucchi KL; Masson C; Rosen A; Clark HW; Robillard H; Banys P; Hall SM
JAMA; 2000 Mar; 283(10):1303-10. PubMed ID: 10714729
[TBL] [Abstract][Full Text] [Related]
17. Gender-specific predictors of retention and opioid abstinence during methadone maintenance treatment.
Levine AR; Lundahl LH; Ledgerwood DM; Lisieski M; Rhodes GL; Greenwald MK
J Subst Abuse Treat; 2015 Jul; 54():37-43. PubMed ID: 25795601
[TBL] [Abstract][Full Text] [Related]
18. Variations in Cannabis Use Level and Correlates in Opiate-Users on Methadone Maintenance Treatment: A French Prospective Study.
Mayet A; Lions C; Roux P; Mora M; Maradan G; Morel A; Michel L; Marimoutou C; Carrieri MP
J Subst Abuse Treat; 2015 Nov; 58():100-5. PubMed ID: 26260134
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C treatment eligibility and comorbid medical illness in methadone maintenance (MMT) and non-MMT patients: a case-control study.
Batki SL; Canfield KM; Smyth E; Ploutz-Snyder R; Levine RA
J Addict Dis; 2010 Jul; 29(3):359-69. PubMed ID: 20635285
[TBL] [Abstract][Full Text] [Related]
20. Trend differences over 20 years between two methadone maintenance clinics, one with and one without cannabis legalization.
Adelson M; Smith D; Peles E
J Addict Dis; 2021; 39(2):226-233. PubMed ID: 33559536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
